Biogen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

10.06.21	Two FDA Committee Members Resign Over Approval Biogen's New Alzheimer's Drug (RTTNews)
10.06.21	New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen’s Commitment to Innovation in SMA Therapy (GlobeNewswire)
07.06.21	Biogen's Aduhelm Gets FDA Approval - A New Drug For Alzheimer's In 18 Years, Priced At $56,000/Yr (RTTNews)
07.06.21	Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access ADUHELM™ (GlobeNewswire)
07.06.21	FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease (GlobeNewswire)
07.06.21	FDA Approves Aduhelm For Alzheimer's Treatment (RTTNews)
01.06.21	Biogen, Bio-Thera Say Phase 3 Study Of BAT1806 Met Its Primary Endpoints - Quick Facts (RTTNews)
01.06.21	Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra® (Tocilizumab) (GlobeNewswire)
21.05.21	Biogen, Ginkgo Bioworks Collaborate To Develop Gene Therapy Manufacturing Platform (RTTNews)
21.05.21	Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform (GlobeNewswire)
20.05.21	Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility in Solothurn, Switzerland (GlobeNewswire)
14.05.21	Biogen's Xirius Phase2/3 Study In XLRO Patients Fails To Meet Primary Endpoints (RTTNews)
14.05.21	Biogen Announces Topline Results From Phase 2/3 Gene Therapy Study for XLRP (GlobeNewswire)
13.05.21	Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research (GlobeNewswire)
12.05.21	Biogen Exercises Option To Acquire TMS-007 For Acute Ischemic Stroke - Quick Facts (RTTNews)
12.05.21	Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data (GlobeNewswire)
10.05.21	Biogen and Capsigen Announce Collaboration to Discover and Develop Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders (GlobeNewswire)
29.04.21	Biogen Provides Regulatory Update on the Supplemental Biologic License Application (sBLA) for Subcutaneous Administration of TYSABRI® (natalizumab) (GlobeNewswire)
28.04.21	Biogen Releases 2020 Year in Review Demonstrating Its Commitment to Transparency and Progress across Environmental, Social and Governance Metrics (GlobeNewswire)
22.04.21	Biogen Boosts FY21 Adj. EPS Outlook; Q1 Results Top Estimates - Quick Facts (RTTNews)
19.04.21	Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients (GlobeNewswire)
16.04.21	New Data at AAN 2021 from Across Biogen’s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis (GlobeNewswire)
15.04.21	Biogen Grows Presence in China with the Approval of TECFIDERA® (dimethyl fumarate) for the Treatment of Relapsing Multiple Sclerosis (GlobeNewswire)
14.04.21	Biogen to Present Trial Design of Aducanumab EMBARK Re-Dosing Study in Poster Session at 2021 Virtual AAN Annual Meeting on April 17-22, 2021 (GlobeNewswire)
12.04.21	Sage Therapeutics : Phase 2 Study Of SAGE-324 In Essential Tremor Meets Primary Endpoint (RTTNews)
09.04.21	Biogen Announces Two New Nominees for Election to Board of Directors (GlobeNewswire)
08.04.21	Biogen To Gain Rights To BAT1806 From Bio-Thera - Quick Facts (RTTNews)
08.04.21	Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis (GlobeNewswire)
07.04.21	Biogen: EC Grants Marketing Authorization For Subcutaneous Injection Of TYSABRI (RTTNews)
07.04.21	The European Commission Grants Marketing Authorization for New Subcutaneous Administration of TYSABRI® (natalizumab) to Treat Relapsing-Remitting Multiple Sclerosis (GlobeNewswire)
04.03.21	Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina (GlobeNewswire)
24.02.21	Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program (GlobeNewswire)
11.02.21	Biogen Announces the Expiration Date Results of Its Cash Tender Offer (GlobeNewswire)
11.02.21	Biogen Announces the Expiration Date Results of Its Private Exchange Offer (GlobeNewswire)
10.02.21	Biogen Announces the Pricing Terms of its Cash Tender Offer (GlobeNewswire)
10.02.21	Biogen Announces the Pricing Terms of Its Private Exchange Offer (GlobeNewswire)
04.02.21	Biogen Announces Cash Tender Offer for 5.200% Senior Notes Due 2045 Open to Certain Holders Only (GlobeNewswire)
04.02.21	Biogen Announces Private Exchange Offer for 5.200% Senior Notes Due 2045 Open to Certain Investors (GlobeNewswire)
04.02.21	BIIB Pulls Plug On Parkinson's Drug, JAZZ Acquires GWPH, NBIX Ends Deal With VYGR, TYME Flies (RTTNews)
03.02.21	Biogen Guides FY21 Below Estimates; Q4 Results Top Estimates - Quick Facts (RTTNews)
03.02.21	Biogen Inc. Q4 adjusted earnings Miss Estimates (RTTNews)
02.02.21	ADMS Gets FDA Nod, ARQT Soars On Psoriasis Trial Data, DVAX Catches Eye, PRTA On Watch (RTTNews)
01.02.21	Biogen Says FDA Approves PLEGRIDY Intramuscular Administration For MS - Quick Facts (RTTNews)
01.02.21	Biogen Announces FDA Approval of PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Multiple Sclerosis (GlobeNewswire)
29.01.21	Biogen, Eisai Say FDA Extends Aducanumab BLA Review Period By Three Months - Quick Facts (RTTNews)
29.01.21	Biogen and Eisai Announce FDA’s 3-Month Extension of Review Period for the Biologics License Application for Aducanumab (GlobeNewswire)
11.01.21	Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone (GlobeNewswire)
08.01.21	Biogen Begins Phase 4 Study Of SPINRAZA In Patients With Suboptimal Response To Gene Therapy (RTTNews)
08.01.21	Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec) (GlobeNewswire)
21.12.20	Biogen's Plegridy Approved In Europe For Intramuscular Injection On RR Multiple Sclerosis (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	500.80	1.23 %	K V
Zurich Insur Gr	534.40	0.94 %	K V
Swiss Re	133.25	0.72 %	K V
Swisscom	511.00	0.69 %	K V
Givaudan	3’871.00	0.60 %	K V
Holcim	84.72	-0.02 %	K V
Nestle	73.60	-0.76 %	K V
Alcon	75.02	-0.90 %	K V
Part Grp Hldg	1’279.00	-0.93 %	K V
CieFinRichemont	138.60	-1.14 %	K V

mehr

12:50		Bayer-Aktie aber freundlich: Bayer kassiert nächste PCB-Niederlage in USA - Warten auf höchstes Staatsgericht
12:26		Freundlicher Handel: TecDAX bewegt sich mittags im Plus
12:26		Freundlicher Handel in Europa: Anleger lassen Euro STOXX 50 mittags steigen
12:26		Handel in Frankfurt: LUS-DAX mittags mit grünem Vorzeichen
12:26		Optimismus in Frankfurt: DAX in Grün
09:28		Gewinne in Europa: Euro STOXX 50 zum Handelsstart mit Gewinnen

12:50

Bayer-Aktie aber freundlich: Bayer kassiert nächste PCB-Niederlage in USA - Warten auf höchstes Staatsgericht

12:26

Freundlicher Handel: TecDAX bewegt sich mittags im Plus

12:26

Freundlicher Handel in Europa: Anleger lassen Euro STOXX 50 mittags steigen

12:26

Handel in Frankfurt: LUS-DAX mittags mit grünem Vorzeichen

12:26

Optimismus in Frankfurt: DAX in Grün

09:28

Gewinne in Europa: Euro STOXX 50 zum Handelsstart mit Gewinnen